Skip to main content
Clinical Trials/NCT07491003
NCT07491003CompletedNot Applicable

Laparoscopic Hiatal Hernia Repair With Mesh Cruroplasty Following Sleeve Gastrectomy: A Prospective Study

Zagazig University1 site in 1 country20 target enrollmentStarted: June 26, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
20
Locations
1
Primary Endpoint
Evaluation of Hiatal Hernia (HH) Recurrence Rate

Study Overview

Brief Summary

The study you're referring to explores a surgical strategy for patients undergoing Laparoscopic Sleeve Gastrectomy (LSG) who also have a Hiatal Hernia (HH). Because obesity is a major risk factor for hiatal hernias, surgeons often find these defects during bariatric procedures

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults (≥18 years), Patients underwent laparoscopic sleeve gastrectomy, Intraoperative confirmation of hiatal hernia, no prior history of esophageal or gastric surgery and Patient fit for general anesthesia

Exclusion Criteria

  • Patients with severe esophageal motility disorders, Patients with contraindications to laparoscopic surgery, Previous hiatal hernia repair, Esophageal stricture and perforation, Pregnancy or uncontrolled comorbidities, Presence of large paraesophageal hernias (>4 cm) with volvulus, Contraindications to laparoscopic surgery, such as severe cardiopulmonary disease and Contraindication for general anesthesia.

Outcomes

Primary Outcomes

Evaluation of Hiatal Hernia (HH) Recurrence Rate

Time Frame: 6 months after the surgical procedure.

The primary objective is to determine the incidence of hiatal hernia recurrence following Laparoscopic Sleeve Gastrectomy (LSG) with concurrent mesh cruroplasty

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Yasser Ali Orban

assisstant professor

Zagazig University

Study Sites (1)

Loading locations...

Similar Trials